Clopidogrel resistance in extremely high cardiovascular risk patients with genotype CYP2C19. Rev. Fed. Arg. Cardiol. [Internet]. 2023 Sep. 28 [cited 2026 Oct. 5];52(3):134-7. Available from: https://www.revistafac.org.ar/ojs/index.php/revistafac/article/view/473